Zevra Therapeutics, Inc. Ratios

Ratios Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 92.81%97.82%92.09%68.59%
EBT Margin 3,341.40%1,525.05%2,045.60%299.96%751.89%1,034.78%-191.17%-96.33%-29.74%-263.80%-167.69%-381.76%
EBIT Margin 3,005.10%1,024.49%854.14%680.13%577.67%1,022.18%-158.40%-42.21%26.98%-418.91%-180.63%-368.47%
EBITDA Margin 3,005.10%1,024.49%854.14%680.13%577.67%1,022.18%-158.40%-42.21%26.98%-418.91%-180.63%-368.47%
Operating Margin 3,005.10%1,024.49%854.14%680.13%577.67%1,022.18%-158.40%-42.21%26.98%-418.91%-180.63%-368.47%
Net Margin 3,328.66%1,526.42%2,046.57%299.69%751.14%1,032.47%-191.00%-96.03%-219.54%-408.85%-167.69%-446.85%
FCF Margin 2,788.54%917.01%763.87%551.90%576.19%991.48%-185.08%-14.84%36.08%-185.12%-123.20%-295.04%
Efficiency
Assets Average 34.15M18.63M10.86M72.08M124.14M143.83M175.23M
Equity Average -36.39M-29.31M-70.51M-70.43M30.35M101.12M68.49M50.77M
Invested Capital -24.27M-48.51M-10.12M-66.57M-74.46M-66.02M127.12M75.12M99.56M99.17M
Asset Utilization Ratio -0.080.691.220.400.080.190.13
Leverage & Solvency
Interest Coverage Ratio -30.05-10.24-8.54-6.80-5.78-10.22-4.19-1.1734.20-127.06-33.05-11.84
Debt to Equity -0.22-1.10-0.010.170.691.50
Debt Ratio 0.790.200.070.110.250.33
Equity Ratio -3.54-0.19-2.49-7.09-5.920.960.650.360.22
Times Interest Earned -30.05-10.24-8.54-6.80-5.78-10.22-4.19-1.1734.20-127.06-33.05-11.84
Valuation
Enterprise Value -1.97M13.95M235.63M57.86M59.36M25.42M9.38M46.57M195.29M76.01M169.49M375.66M
Market Capitalization 286.95M57.86M59.36M47.09M12.60M50.78M307.63M158.38M237.23M445.16M
Return Ratios
Return on Sales 33.29%15.26%20.47%3.00%7.51%10.32%-1.91%-0.96%-0.30%-2.63%-1.68%-4.47%
Return on Capital Employed -0.88%-1.54%-1.69%0.11%-0.38%-0.71%-0.62%
Return on Invested Capital 0.29%0.08%-0.42%
Return on Assets -1.60%-1.32%-1.18%-0.12%-0.22%-0.32%-0.60%
Return on Equity 0.67%1.86%0.35%0.18%-0.28%-0.26%-0.67%-2.08%